Revolutionizing IBD Care

On behalf of the Crohn’s & Colitis Foundation and the American Gastroenterological Association, thank you to our attendees, Congress Chairs, faculty, industry supporters, exhibitors, and partners for making the 2025 Crohn’s & Colitis Congress® a success.

We look forward to seeing you in Las Vegas on January 22–24, 2026.

We are thrilled to bring you the ninth annual Crohn’s & Colitis Congress®, taking place in Las Vegas, on January 22-24, 2026. Once again, the Crohn’s & Colitis Foundation and the American Gastroenterological Association are collaborating on the ultimate conference for inflammatory bowel disease (IBD) professionals. The Congress continues to innovate, inspire, and bring together a multidisciplinary community of health care professionals, researchers and industry dedicated to revolutionizing IBD care.

An exciting range of fresh and favorite topics will be covered during interactive presentations, engaging breakout sessions and inclusive panel discussions. Whether you are a clinician, scientist, or provider in any IBD-related field, the Congress is an invaluable experience, delivering the latest research and technological breakthroughs, novel treatment scenarios, unparalleled networking with new colleagues and old friends, and so much more!

We look forward to seeing you in Las Vegas and working together to progress prevention, care and outcomes for people living with IBD.

Registration is schedule to open by July 23, so stay tuned for updates and keep checking here for the latest news. See you in Vegas!

2022 Crohn's & Colitis Congress Goes Virtual

The Crohn’s & Colitis Foundation and AGA have cancelled in-person programming due to the challenges the coronavirus omicron variant outbreak places on the medical community. In order to have the safest and most educational meeting, all Crohn’s & Colitis Congress programming will be held virtually on January 20-22. 

Speakers, moderators and poster presenters will receive more details by email later this week about your virtual participation.

Exhibitors will be contacted directly by a member of Congress management for further details. 

Attendees: All registrations will be converted to virtual and housing reservations will be cancelled.

We look forward to a dynamic and educational virtual and on-demand experience.  Thank you for your patience with this transition. We share our best wishes for your health and safety.

 

WE HOPE TO SEE YOU VIRTUALLY ON JANUARY 20–22, 2022. 

Upcoming Dates

Marriott Marquis Hotel Deadline Extension: Wednesday, January 29, 2025

Standard Registration Deadline: Wednesday, February 5, 2025

Important Dates

Registration

Registration Opens: Wednesday, July 23, 2025
Early Registration Deadline: Tuesday, September 2, 2025
Advanced Registration Deadline: Tuesday, October 21, 2025
Discounted Registration Deadline: Tuesday, December 9, 2025
Standard Registration Deadline: Tuesday, January 20, 2026

Abstract Submission

Abstract Submission Opens: Wednesday, August 13, 2025
Abstract Submission Deadline: Wednesday, September 24, 2025
Abstract Notification: Monday, November 17, 2025

Why You Should Attend the Crohn’s & Colitis Congress

Drs. Peter Higgins and Laura Raffals reveal why they are excited to bring you the 2024 Congress.

You can still register to join the live meeting. If you miss anything, the on-demand programming will be released on February 1, 2021, and be available for 90 days.

2026 Crohn's & Colitis Congress Chairs

Jessica Allegretti, MD, MPH, AGAF

Co-Chair, Organizing Committee
Brigham and Women's Hospital

Karen Edelblum, PhD

Co-Chair, Organizing Committee
Icahn School of Medicine at Mount Sinai

Christina Ha, MD, AGAF

Co-Chair, Organizing Committee
Mayo Clinic

Andres J. Yarur, MD, AGAF

Chair-Elect, Organizing Committee
Cedars-Sinai

Supporting Organization

The 2025 Crohn’s & Colitis Congress was supported by an educational grant from: 

Ferring Pharmaceuticals, Inc.

Lilly

Pfizer

Takeda Pharmaceuticals U.S.A., Inc.

Salix Pharmaceuticals, Inc.

Bristol Myers Squibb

AbbVie Inc.

Salix Pharmaceuticals, a division of Bausch Health US, LLC

Pfizer Inc.

Takeda Pharmaceuticals U.S.A., Inc.

Recognition

The 2025 Crohn’s & Colitis Congress partnered with:

Media Partners

Special thanks to our 2025 Crohn’s & Colitis Congress® partners:

This website uses cookies to provide you with the best experience on our website. If you wish to disable cookies, please do so in your browser settings. Your continued use of our site without disabling your cookies is subject to the cookie policy. Learn More